Global biopharmaceutical company MSD has appointed Rehan A. Khan as Managing Director, India Region. He will be assuming responsibility from January 13, 2020.
While announcing the leadership appointment, Dorthe Mikkelsen, President Asia Pacific Region, MSD said, “Rehan is an accomplished international leader who has led large and complex multinational businesses, covering India, Greater China, Southeast Asia, and across Asia Pacific with leading multinational companies. His expertise, experience and industry know-how will be invaluable in driving MSD’s business in India and helping achieve our vision for patient access to critical therapies”.
With over 20 years of in-depth industry experience, Rehan has worked as President of Asia Pacific with an NYSE-listed dialysis services provider, which has presence across 50 cities in Asia. Prior to that he was Managing Director of a leading pharmaceutical multinational company in India.
More recently, Rehan was working as an entrepreneur and Founder of First Penguin Capital, an early stage fund focused on investing in health and consumer tech startups. Also, a board member and advisor to several impact led Private Equity funds and to healthcare companies in Africa, India, and South East Asia, he has been associated with the Healthcare sector for some time now.
The Indian pharmaceutical market has the potential to reach USD 70 billion in an aggressive growth scenario. Driven by technological advancements, biopharmaceutical is one the evolving aspects of the sector. However, it requires huge investments in terms of both skills and money. For MSD India ensuring the right capabilities to make of the available market opportunity would be a key priority. And as Rehan takes charge to lead its business how he drives the company's growth and what new strategies he introduces is to look forward to.